CareLit · DOI-Nachweis · Aktuelle Neurologie
Re-challenge with temozolomide at recurrence in high-grade gliomas
DOI 10.1055/s-2007-987519
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Hau, CP Beier, D Beier, O Grauer, B Hirschmann, T Jauch, C Wismeth, M Proescholdt, U Bogdahn
ZeitschriftAktuelle Neurologie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Temozolomide (TMZ) is standard therapy for patients (pts) with high-grade gliomas (HGG). Recent data suggest potentially enhanced efficacy of alternative schedules of TMZ administration based on optimizing depletion of MGMT. However, no prospective data have been published on the efficacy of TMZ regimens after failure of first-line TMZ (FL-TMZ). We therefore assessed the outcome of rechallenge with TMZ i…
Zitieren
Zitierempfehlung
P Hau, CP Beier, D Beier, O Grauer, B Hirschmann, T Jauch, C Wismeth, M Proescholdt, U Bogdahn (2007) Re-challenge with temozolomide at recurrence in high-grade gliomas. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2007-987519
Mit CareLit weiterarbeiten